Disposable technology is being used more each year in the biotechnology industry. Disposable bioreactors allow the user to avoid expenses associated with cleaning, assembly and operations, as well as equipment validation. Disposable bioreactors have played a key role to meet the increasing run rate of the Cell Culture Pilot Plant while maintaining a high success rate, reducing labor costs, increasing efficiency, and lowering the risk of contamination. Recent effort to evaluate the next generation 10:1 turndown single use bioreactor with different cell retention devices to challenges oxygen mass transfer, carbon-dioxide stripping while assessing foaming, and vent filter sizing. This presentation will focus primarily on the advantage of the...
For cultivation of mammalian cells in biopharmaceutical research and manufacturing, single-use techn...
Pfizer Bioprocessing R&D is focused on developing enabling technologies that will reduce capital and...
In response to increased demands placed on biopharmaceutical manufacturers to diversify portfolios a...
Operating bioreactor vessels at low working volumes (high turn-down ratio) is often desirable but br...
In a fully disposable facility where the use of continuous disk-stack centrifuges are not preferred,...
Disposable bioreactors have increasingly been incorporated into preclinical, clinical, and productio...
Disposable technology is being used more each year in the biotechnology industry. Disposable bioreac...
In a fully disposable facility where the use of continuous disk-stack centrifuges are not preferred,...
Establishing comparability in SUT facilities for processes that were previously run in stainless ste...
Despite wide-spread use of disposable bioreactors, there is a lack of well-established scale-down mo...
Industry trends in regenerative medicine highlight a critical need for closed, single use cell cultu...
Erworben im Rahmen der Schweizer Nationallizenz (http://www.nationallizenzen.ch)Disposable bioreacto...
Improvements in single-use systems have allowed implementation of high-density cultures in emerging ...
Please click Additional Files below to see the full abstract. Please click Download on the upper rig...
The Center for Integrated Biosystems (CIB) at Utah State University proposed to demonstrate the adde...
For cultivation of mammalian cells in biopharmaceutical research and manufacturing, single-use techn...
Pfizer Bioprocessing R&D is focused on developing enabling technologies that will reduce capital and...
In response to increased demands placed on biopharmaceutical manufacturers to diversify portfolios a...
Operating bioreactor vessels at low working volumes (high turn-down ratio) is often desirable but br...
In a fully disposable facility where the use of continuous disk-stack centrifuges are not preferred,...
Disposable bioreactors have increasingly been incorporated into preclinical, clinical, and productio...
Disposable technology is being used more each year in the biotechnology industry. Disposable bioreac...
In a fully disposable facility where the use of continuous disk-stack centrifuges are not preferred,...
Establishing comparability in SUT facilities for processes that were previously run in stainless ste...
Despite wide-spread use of disposable bioreactors, there is a lack of well-established scale-down mo...
Industry trends in regenerative medicine highlight a critical need for closed, single use cell cultu...
Erworben im Rahmen der Schweizer Nationallizenz (http://www.nationallizenzen.ch)Disposable bioreacto...
Improvements in single-use systems have allowed implementation of high-density cultures in emerging ...
Please click Additional Files below to see the full abstract. Please click Download on the upper rig...
The Center for Integrated Biosystems (CIB) at Utah State University proposed to demonstrate the adde...
For cultivation of mammalian cells in biopharmaceutical research and manufacturing, single-use techn...
Pfizer Bioprocessing R&D is focused on developing enabling technologies that will reduce capital and...
In response to increased demands placed on biopharmaceutical manufacturers to diversify portfolios a...